GLAZER CAPITAL, LLC

Position in DMAA — Drugs Made In America Acquisition Corp.

CIK 1076809 New York, NY

Position in DMAA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$17,589,694

-$1,253,930 QoQ

Shares Held

1,678,406

-7.6% QoQ

Ownership

6.91%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

of 39 holders

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Financial Services · as of Mar 31, 2026

GLAZER CAPITAL, LLC holds $1,051,930,635 across 180 Shell Companies names. DMAA ranks #5 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DMII	Drugs Made In America Acquisition II Corp.	2,349,761	$23,427,117
2	GIW	GigCapital8 Corp.	2,162,974	$21,564,850
3	GIX	GigCapital9 Corp.	2,178,000	$21,409,740
4	EVAC	EQV Ventures Acquisition Corp. II	1,828,369	$18,448,243
5	DMAA	Drugs Made In America Acquisition Corp. This page	1,678,406	$17,589,694
6	TACO	Berto Acquisition Corp.	1,578,382	$16,178,415
7	DBCA	D. Boral Acquisition I Corp.	1,620,044	$15,973,633
8	OYSE	Oyster Enterprises II Acquisition Corp	1,550,000	$15,763,500

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,589,694	1,678,406	-7.6%	Shares	Sole	2026-05-14
2025-12-31	$18,843,624	1,816,428	-0.3%	Shares	Sole	2026-02-13
2025-09-30	$18,714,938	1,822,292	-0.0%	Shares	Sole	2025-11-13
2025-06-30	$18,588,990	1,822,450	-0.0%	Shares	Sole	2025-08-14
2025-03-31	$18,265,979	1,822,952	0.0%	Shares	Sole	2025-05-15
2025-03-31	$18,265,979	1,822,952	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.